M
Mona Saraiya
Researcher at Centers for Disease Control and Prevention
Publications - 258
Citations - 18861
Mona Saraiya is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Cervical cancer & Population. The author has an hindex of 57, co-authored 247 publications receiving 15391 citations. Previous affiliations of Mona Saraiya include American Society for Clinical Pathology.
Papers
More filters
Journal ArticleDOI
Estimates of Incidence and Mortality of Cervical Cancer in 2018: A Worldwide Analysis
Marc Arbyn,Elisabete Weiderpass,Laia Bruni,Silvia de Sanjosé,Mona Saraiya,Jacques Ferlay,Freddie Bray +6 more
TL;DR: The global scale-up of HPV vaccination and HPV-based screening—including self-sampling—has potential to make cervical cancer a rare disease in the decades to come, and could help shape and monitor the initiative to eliminate cervical cancer as a major public health problem.
Journal Article
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Lauri E. Markowitz,Eileen F. Dunne,Mona Saraiya,Herschel W. Lawson,Harrell W. Chesson,Elizabeth R. Unger +5 more
TL;DR: The first statement by the Advisory Committee on Immunization Practices (ACIP) on the use of a quadrivalent human papillomavirus (HPV) vaccine was made by the U.S. Food and Drug Administration on June 8, 2006 as mentioned in this paper.
Journal ArticleDOI
Worldwide burden of cervical cancer in 2008
Marc Arbyn,Marc Arbyn,Xavier Castellsagué,S de Sanjosé,Laia Bruni,Mona Saraiya,Freddie Bray,Jacques Ferlay +7 more
TL;DR: In spite of effective screening methods, cervical cancer continues to be a major public health problem and new methodologies of cervical cancer prevention should be made available and accessible for women of all countries through well-organised programmes.
Journal Article
Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.
Emiko Petrosky,Joseph A. Bocchini,Susan Hariri,Harrell W. Chesson,C. Robinette Curtis,Mona Saraiya,Elizabeth R. Unger,Lauri E. Markowitz +7 more
TL;DR: Evidence considered by ACIP in recommending 9vHPV as one of three HPV vaccines that can be used for vaccination is summarized and recommendations for vaccine use are provided.
Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Lauri E. Markowitz,Eileen F. Dunne,Mona Saraiya,Harrell W. Chesson,Curtis Cr,Julianne Gee,Joseph A. Bocchini,Elizabeth R. Unger +7 more
TL;DR: This report summarizes the epidemiology of human papillomavirus (HPV) and associated diseases, describes the licensed HPV vaccines, provides updated data from clinical trials and postlicensure safety studies, and compiles recommendations from CDC's Advisory Committee on Immunization Practices (ACIP) for use of HPV vaccines.